glp 1 class of drugs Lesson: Oral Semaglutide: A New GLP-1 Receptor Agonist Product for the Treatment Type 2 Diabetes How to Find a Health
Description
| CBS News
Lebrun LJ, Lenaerts K, Kiers D, Pais de Barros JP, Le Guern N, Plesnik J, et al
Chen JS, Copado IA, Vallejos C, et al
13 More than half of adults taking these medications reported having difficulty affording them
The Trump administration announced initiatives in November 2025 to expand GLP-1 access for Medicare beneficiaries with obesity plus significant comorbidities, with implementation expected around mid-2026
Safety and Considerations: Common side effects associated with these medications such as nausea, diarrhea, or changes in appetite
